Side effects are not judged by whether they sound minor on paper
(Source: ScienceDaily, 2025) Semaglutide Delivers Major Weight Loss in Adults Over 65 A 2026 study presented at the European Association for the Study of Obesity found that older adults (65+) taking once-weekly semaglutide experienced substantial weight loss and improvements in multiple health measures with results similar to those seen in the broader STEP trial population
Sustainable weight loss is most likely to be achieved by combining GLP-1 therapy with healthy habits like a nutritious, balanced diet, regular exercise, and adequate sleep
Rarely exfoliative dermatitis may occur
Optimal Protein Intake: Protein is essential to the synthesis and maintenance of lean muscle, major organs, and metabolic functions in the body
The use of GLP-1 medications in older adults has yet to be thoroughly studied in prospective clinical trials. Likewise, anyone with baseline osteopenia or osteoporosis may be at risk of a further decrease in bone density and an increased risk of falls and fractures, he added